| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |